A Drug-Resistant Superbug May Be Stealthily Spreading

Person-to-person transmission of carbapenem-resistant Enterobacteriaceae in US hospitals may be occurring without symptoms, a new study suggests.

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

CRE (right) can grow in the presence of antibiotics CDC

The drug-resistant carbapenem-resistant Enterobacteriaceae (CRE) may be capable of spreading in more ways—and more insidiously—than previously thought, according to a study published January 16 in PNAS. CREs are resistant to multiple antibiotics including last-resort drugs like carbapenem, and have been called “nightmare” bacteria by Tom Frieden, director of the Centers for Disease Control and Prevention.

Researchers at the Broad Institute of MIT and Harvard analyzed 250 CRE samples from patients across four US hospitals, three in Boston and one in California. They found that the bacteria not only displayed remarkable genetic diversity and a variety of carbapenem resistance genes, but they were able to transfer resistance genes between species.

Although the researchers were unable to find much evidence of person-to-person transmission, CREs may be spreading ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Diana Kwon

    Diana is a freelance science journalist who covers the life sciences, health, and academic life.
Share
TS Digest January 2025
January 2025, Issue 1

Why Do Some People Get Drunk Faster Than Others?

Genetics and tolerance shake up how alcohol affects each person, creating a unique cocktail of experiences.

View this Issue
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino
New Approaches for Decoding Cancer at the Single-Cell Level

New Approaches for Decoding Cancer at the Single-Cell Level

Biotium logo
Learn How 3D Cell Cultures Advance Tissue Regeneration

Organoids as a Tool for Tissue Regeneration Research 

Acro 

Products

Artificial Inc. Logo

Artificial Inc. proof-of-concept data demonstrates platform capabilities with NVIDIA’s BioNeMo

Sapient Logo

Sapient Partners with Alamar Biosciences to Extend Targeted Proteomics Services Using NULISA™ Assays for Cytokines, Chemokines, and Inflammatory Mediators

Bio-Rad Logo

Bio-Rad Extends Range of Vericheck ddPCR Empty-Full Capsid Kits to Optimize AAV Vector Characterization

Scientist holding a blood sample tube labeled Mycoplasma test in front of many other tubes containing patient samples

Accelerating Mycoplasma Testing for Targeted Therapy Development